peer reviewedObjective: Belgian genetic centers established a database containing data on all chromosomal microarrays performed in a prenatal context. A study was initiated to evaluate postnatal development in children diagnosed prenatally with a non-benign copy number variant (CNV). Methods: All children diagnosed with a prenatally detected non-benign CNV in a Belgian genetic center between May 2013 and February 2015 were included in the patient population. The control population consisted of children who had undergone an invasive procedure during pregnancy, with no or only benign CNVs. Child development was evaluated at 36 months using three (3) questionnaires: Ages and Stages Questionnaire Third edition, Ages and Stages Questionnaire Soc...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
PURPOSE: Noninvasive prenatal screening (NIPS) using genome sequencing also reveals maternal copy-nu...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
Objective Belgian genetic centers established a database containing data on all chromosomal microarr...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Abstract Background The implementation of genomic testing in pregnancy means that couples have acces...
International audienceObjective - To determine the frequency and nature of copy number variants (CNV...
Objectives : Since 2013, samples for prenatal diagnosis in Belgium are analysed by Chromosomal Micro...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
PURPOSE: Noninvasive prenatal screening (NIPS) using genome sequencing also reveals maternal copy-nu...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
OBJECTIVE: Belgian genetic centers established a database containing data on all chromosomal microar...
Objective Belgian genetic centers established a database containing data on all chromosomal microarr...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
OBJECTIVE: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Objective: With the replacement of karyotyping by chromosomal microarray (CMA) in invasive prenatal ...
Abstract Background The implementation of genomic testing in pregnancy means that couples have acces...
International audienceObjective - To determine the frequency and nature of copy number variants (CNV...
Objectives : Since 2013, samples for prenatal diagnosis in Belgium are analysed by Chromosomal Micro...
BACKGROUND: The genomic contribution to adverse health sequelae in babies born very preterm (<32 wee...
ObjectiveTo evaluate the effectiveness of non-invasive prenatal screening (NIPS) in prenatal screeni...
PURPOSE: Noninvasive prenatal screening (NIPS) using genome sequencing also reveals maternal copy-nu...